Evaluating Potential Impacts of Climate-Related Natural Disasters on Subsequent Prostate Cancer Mortality.
1/5 보강
[BACKGROUND] Climate-related disruptions to the health system may impact cancer outcomes.
- 표본수 (n) 50
- 95% CI 1.02-1.30
- RR 1.15
APA
Cole AP, Qian Z, et al. (2026). Evaluating Potential Impacts of Climate-Related Natural Disasters on Subsequent Prostate Cancer Mortality.. Cancer medicine, 15(2), e71618. https://doi.org/10.1002/cam4.71618
MLA
Cole AP, et al.. "Evaluating Potential Impacts of Climate-Related Natural Disasters on Subsequent Prostate Cancer Mortality.." Cancer medicine, vol. 15, no. 2, 2026, pp. e71618.
PMID
41674181 ↗
Abstract 한글 요약
[BACKGROUND] Climate-related disruptions to the health system may impact cancer outcomes. This may be particularly true for prostate cancer, which greatly contributes to cancer burden while existing on a risk spectrum, leading some men to delay treatment even in advanced cases.
[METHODS] The study included men diagnosed with metastatic prostate cancer from 2010 to 2020 within SEER-supported counties that experienced a climate-related natural disaster from 2012 to 2018. A smaller subgroup of "major" disasters was classified based on individual assistance from FEMA. Year of natural disaster was considered the index date, with 2-year pre- and post-disaster periods compared. Age-standardized incidence-based metastatic prostate cancer mortality (IBM) rates were extracted from SEER and adjusted for demographics. Counties were then compared 147 SEER counties without any climate-related natural disaster.
[RESULTS] There were 222 counties across 11 states experiencing a single disaster within the study period, covering an estimated 27,787,120 people. Compared to the index year, prostate cancer IBM was 15% higher (RR: 1.15, 95% CI 1.02-1.30) 1-year post-disaster and 28% higher (RR: 1.28, 95% CI 1.11-1.49) 2 years post-disaster. Associations were stronger among counties (n = 50) experiencing a "major" disaster (RR: 1.21, 95% CI: 1.05-1.40) and 35% (RR: 1.35, 95% CI: 1.17-1.55) at 1 and 2 years. In non-exposed counties, this pattern was absent.
[CONCLUSIONS] We report a significant, dose-dependent change in mortality from metastatic prostate cancer following a climate-related natural disaster. The reasons are speculative but may include delayed diagnosis, care fragmentation, and interruptions for treatments for advanced disease including chemotherapy and radio-hormonal therapy.
[METHODS] The study included men diagnosed with metastatic prostate cancer from 2010 to 2020 within SEER-supported counties that experienced a climate-related natural disaster from 2012 to 2018. A smaller subgroup of "major" disasters was classified based on individual assistance from FEMA. Year of natural disaster was considered the index date, with 2-year pre- and post-disaster periods compared. Age-standardized incidence-based metastatic prostate cancer mortality (IBM) rates were extracted from SEER and adjusted for demographics. Counties were then compared 147 SEER counties without any climate-related natural disaster.
[RESULTS] There were 222 counties across 11 states experiencing a single disaster within the study period, covering an estimated 27,787,120 people. Compared to the index year, prostate cancer IBM was 15% higher (RR: 1.15, 95% CI 1.02-1.30) 1-year post-disaster and 28% higher (RR: 1.28, 95% CI 1.11-1.49) 2 years post-disaster. Associations were stronger among counties (n = 50) experiencing a "major" disaster (RR: 1.21, 95% CI: 1.05-1.40) and 35% (RR: 1.35, 95% CI: 1.17-1.55) at 1 and 2 years. In non-exposed counties, this pattern was absent.
[CONCLUSIONS] We report a significant, dose-dependent change in mortality from metastatic prostate cancer following a climate-related natural disaster. The reasons are speculative but may include delayed diagnosis, care fragmentation, and interruptions for treatments for advanced disease including chemotherapy and radio-hormonal therapy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.